Steven Lichtman
Stock Analyst at Oppenheimer
Total Price Targets
19
Stocks Covered
12
Sectors
Healthcare
Most Recent
Oct 15, 2024
Stocks Covered by Steven Lichtman
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| ZBH | Zimmer Biomet Holdings, Inc. | $135.00 | $83.24 | +62.2% | 3 | Oct 15, 2024 |
| MNKD | MannKind Corporation | $12.00 | $2.87 | +318.8% | 1 | Aug 28, 2024 |
| PODD | Insulet Corporation | $233.00 | $175.12 | +33.1% | 2 | Aug 27, 2024 |
| ALC | Alcon Inc. | $110.00 | $74.45 | +47.8% | 1 | Aug 22, 2024 |
| MDT | Medtronic plc | $94.00 | $80.42 | +16.9% | 1 | Aug 21, 2024 |
| DXCM | DexCom, Inc. | $115.00 | $61.51 | +87.0% | 4 | Jul 26, 2024 |
| TNDM | Tandem Diabetes Care, Inc. | $58.00 | $19.34 | +199.9% | 1 | Jun 10, 2024 |
| RXST | RxSight, Inc. | $72.00 | $7.33 | +881.6% | 1 | May 7, 2024 |
| BSX | Boston Scientific Corporation | $77.00 | $56.91 | +35.3% | 2 | Apr 25, 2024 |
| ANGO | AngioDynamics, Inc. | $12.00 | $11.22 | +7.0% | 1 | Apr 5, 2024 |
| SYK | Stryker Corporation | $288.00 | $297.71 | -3.3% | 1 | Jul 28, 2021 |
| GMED | Globus Medical, Inc. | $79.00 | $91.62 | -13.8% | 1 | May 5, 2021 |
Recent Activity
- Oct 15, 2024— Set$135.00price target onZBH(Zimmer Biomet Holdings, Inc.)
- Aug 28, 2024— Set$12.00price target onMNKD(MannKind Corporation)
- Aug 27, 2024— Set$233.00price target onPODD(Insulet Corporation)
- Aug 22, 2024— Set$110.00price target onALC(Alcon Inc.)
- Aug 21, 2024— Set$94.00price target onMDT(Medtronic plc)
- Aug 8, 2024— Set$145.00price target onZBH(Zimmer Biomet Holdings, Inc.)
- Jul 26, 2024— Set$115.00price target onDXCM(DexCom, Inc.)
- Jun 10, 2024— Set$58.00price target onTNDM(Tandem Diabetes Care, Inc.)
- Jun 3, 2024— Set$150.00price target onDXCM(DexCom, Inc.)
- May 7, 2024— Set$72.00price target onRXST(RxSight, Inc.)
- Apr 25, 2024— Set$77.00price target onBSX(Boston Scientific Corporation)
- Apr 5, 2024— Set$12.00price target onANGO(AngioDynamics, Inc.)
- Oct 27, 2023— Set$122.00price target onDXCM(DexCom, Inc.)
- Jan 31, 2022— Set$275.00price target onPODD(Insulet Corporation)
- Jan 31, 2022— Set$36.25price target onDXCM(DexCom, Inc.)
- Aug 4, 2021— Set$190.00price target onZBH(Zimmer Biomet Holdings, Inc.)
- Jul 28, 2021— Set$288.00price target onSYK(Stryker Corporation)
- May 5, 2021— Set$79.00price target onGMED(Globus Medical, Inc.)
- Apr 28, 2021— Set$47.00price target onBSX(Boston Scientific Corporation)
Frequently Asked Questions
Who is Steven Lichtman?
Steven Lichtman is a stock analyst at Oppenheimer covering 12 stocks primarily in Healthcare. They have issued 19 price targets since Apr 28, 2021.
What stocks does Steven Lichtman cover?
Steven Lichtman currently covers 12 stocks, including DXCM, ZBH, PODD, BSX, MNKD.
What is Steven Lichtman's latest price target?
Steven Lichtman's most recent price target was $135.00 on ZBH (Zimmer Biomet Holdings, Inc.), set on Oct 15, 2024.
What is Steven Lichtman's highest price target?
Steven Lichtman's highest issued price target is $288.00 on SYK, set on Jul 28, 2021.
More Analysts at Oppenheimer
Coverage based on publicly published price targets. Not investment advice.